Marpai CEO-linked fund buys 896,903 MRAI shares
Marpai, Inc. director, Chief Executive Officer, and over-10% holder Damien Lamendola reported an indirect open‑market purchase of 896,903 shares of Class A common stock at an average price of $1.0592 per share.
Rhea-AI Filing Summary
Marpai, Inc. director, Chief Executive Officer, and over-10% holder Damien Lamendola reported an indirect open‑market purchase of 896,903 shares of Class A common stock at an average price of $1.0592 per share. The shares are held by entities including HillCour Investment Fund, LLC and WellEnterprises USA, LLC, over which he holds voting and dispositive power. Following these transactions, his reported holdings include 6,272,835 indirect shares, 800,000 direct shares, and an additional 931,674 indirect shares of Class A common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Class A Common Stock | 896,903 | $1.0592 | $950K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Held by HillCour Investment Fund, LLC, of which Mr. Lamendola is the Manager, and holds the voting and dispositive power over the securities held by HillCour Investment Fund, LLC.
- F2. Held by WellEnterprises USA, LLC, a wholly owned subsidiary of HillCour, Inc., which is wholly owned by HillCour Holding Corporation, a corporation controlled by Mr. Lamendola. Mr. Lamendola holds the voting and dispositive power over the securities held by WellEnterprises USA, LLC.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Marpai (MRAI) report for Damien Lamendola?
AI-generated analysis. How Rhea-AI works. Not financial advice.